INPLASY202650166 SGLT2 Inhibitors in Cardiorenal Protection: Protocol for a Systematic Review and Meta-Analysis of Efficacy, Safety, and Early Intervention Evidence Keywords: SGLT2 inhibitors; cardiorenal protection; chronic kidney disease; heart failure; cardiovascular outcomes; dapagliflozin; empagliflozin; canagliflozin; meta-analysis; systematic review. Read and download full-text here - PDF 202650166 Review Status: ongoing
